Ropes & Gray advised Oberland Capital on the successful closing of its second royalty and credit opportunities fund, Oberland Capital Healthcare II LP, which announced that it closed at its hard cap of $800 million in capital commitments on Sept. 6.
Fund II will target investments between $20 million and $150 million with a focus on commercial stage or near-commercial stage biopharmaceutical, medical device and diagnostic companies and royalty-bearing products. Investors in Fund II include public and corporate pension plans, financial institutions, foundations and endowments located in the United States, Europe and the Middle East.
Founded in 2013, Oberland Capital, is a private investment firm that is focused exclusively on investing in the global healthcare industry and specializes in flexible investment structures customized to meet the specific capital requirements and strategic objectives of transaction partners.
The Ropes & Gray team was led by private investment funds partner Marc Biamonte, and included investment management partner Mike Doherty, tax partner Dan Kolb, tax counsel Seth Piken, and corporate paralegal James Janison.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.